MRVI - Maravai LifeSciences Holdings, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$5.25
DETAILS
HIGH:
$6.00
LOW:
$4.50
MEDIAN:
$5.25
CONSENSUS:
$5.25
UPSIDE:
19.32%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 18.0% |
| EBIT Margin | -112.0% |
| EBITDA Margin | -79.2% |
| Operating Margin | -3.6% |
| Pretax Margin | -126.5% |
| Cont. Ops Margin | -124.2% |
| Net Margin | -70.4% |
| Bottom Line Margin | -70.4% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 6.60 |
| Quick Ratio | 5.69 |
| Solvency Ratio | -0.176 |
| Cash Ratio | 4.83 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings | |
| PEG Ratio | 0.27 |
| Forward PEG | 0.27 |
| Price/Book | 2.22 |
| Price/Sales | 2.54 |
| Price/FCF | -6.67 |
| Price/Op Cash Flow | -8.19 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0462 |
| Debt/Equity | 0.1675 |
| Debt/Capital | 0.1435 |
| Long-Term Debt/Capital | 0.1243 |
| Financial Leverage | 3.63 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.60 |
| Operating Cash Flow Ratio | -1.282 |
| Operating Cash Flow/Sales | -31.0% |
| Free Cash Flow/Operating Cash Flow | 122.8% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -4.41 |
| Interest Coverage | -0.2496 |
| Short-Term Operating Cash Flow Coverage | -10.58 |
| Operating Cash Flow Coverage | -1.62 |
| Capital Expenditure Coverage | -4.38 |
| Dividend + Capital Expenditure Coverage | -4.38 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 1.28 |
| EPS | -0.901 |
| Debt/Share | 0.4313 |
| Cash/Share | 1.50 |
| Book Value/Share | 2.57 |
| Tangible BV/Share | 0.63 |
| Equity/Share | 1.46 |
| Operating Cash Flow/Share | -0.397 |
| Capital Expenditure/Share | 0.091 |
| FCF/Share | -0.487 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.557 |
| Earnings Before Tax/EBIT | 34.873 |
| Price/Fair Value | 2.22 |
| Debt/Market Cap | 0.0396 |
| Effective Tax Rate | 1.8% |
| Enterprise Value Multiple | -4.87 |